PATENTS
Practice
Appeal from Federal Court order (2005 FC 1283) dismissing application for prohibition preventing Minister of Health from issuing notice of compliance in respect of Apotex’ drug product ramipril until after expiration of Canadian Letters Patent No. 1341206—Sound prediction of utility, burden of proof if alleging invalidity of listed patent—Appeal dismissed.
Aventis Pharma Inc. v. Apotex Inc. (A‑431‑05, 2006 FCA 64, Richard C.J., judgment dated 13/2/06, 14 pp.)
You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.